...
首页> 外文期刊>Revista Argentina de Cardiologia >Estrategias de tratamiento en el síndrome coronario agudo con elevación del segmento ST en la provincia de Tierra del Fuego, República Argentina: Registro SCACEST TDF
【24h】

Estrategias de tratamiento en el síndrome coronario agudo con elevación del segmento ST en la provincia de Tierra del Fuego, República Argentina: Registro SCACEST TDF

机译:阿根廷共和国火地岛省ST段抬高急性冠脉综合征的治疗策略:STEACS TDF注册中心

获取原文
           

摘要

Introduction and Objectives Due to the particular geographical and population characteristics of Tierra del Fuego province, an ST-segment elevation acute coronary syndrome (STEACS) registry assessing epidemiological, clinical, diagnostic and therapeutic aspects was conducted in patients admitted with this condition to establish optimal treatment strategies. Methods This study was a prospective registry in 47 consecutive patients admitted with less than 12-hour STEACS evolution in the four middle and high complexity centers of the province from the beginning of November 2009 to the end of October 2010. Results Mean age was 55 ± 10.1 years, and 89.4% were men. The annual incidence of cases was 3.72/10000 inhabitants. Seventeen percent of patients had history of myocardial infarction and 19.2% had undergone coronary angioplasty or myocardial revascularization surgery. Reperfusion therapy was performed on 85.1% of patients: 57.4% with fibrinolytic agents and 27.7% with primary angioplasty. Median pain to door time was 145 minutes (interquartile range 60-240) and door to reperfusion time was 42.5 minutes (25-240). Mortality was 8.5% and heart failure was present in 19.1% of patients. Conclusions A high percentage of patients underwent reperfusion therapy. Delays to treatment occurred in the pre-hospital stage.
机译:引言和目标由于火地岛省的特殊地理和人口特征,对患有这种情况的患者进行了ST段抬高急性冠状动脉综合征(STEACS)登记册,评估流行病学,临床,诊断和治疗方面,以建立最佳治疗方案策略。方法该研究是一项前瞻性研究,从2009年11月开始至2010年10月下旬,在该省的四个中高复杂性中心连续收治了少于12小时的STEACS演变的患者。结果平均年龄为55±男性占10.1岁,占89.4%。每年的病例发生率为3.72 / 10000居民。 17%的患者有心肌梗塞病史,19.2%的患者接受了冠状动脉成形术或心肌血运重建手术。 85.1%的患者进行了再灌注治疗:纤溶剂占57.4%,原发性血管成形术占27.7%。门疼痛时间中位数为145分钟(四分位间距60-240),门再灌注时间为42.5分钟(25-240)。死亡率为8.5%,心力衰竭的患者为19.1%。结论高比例的患者接受了再灌注治疗。延迟治疗发生在医院前阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号